Actual device remains implanted in the patient's eye and was not evaluated.The instructions for use for the kamra inlay, involving both the united states (us) and outside the united states (ous) product labeling (ifu p/n's 61017 and 61016-05, respectively), contain statements warning against the creation of a femtosecond laser flap with the kamra inlay in place.The doctor involved in this event was informed of this warning and signed an acknowledgement on (b)(6) 2014 which is on file at acufocus, inc.Device remains implanted in the patient.
|
On (b)(6) 2015, the doctor reported he cut a femtosecond (f/s) flap on a patient that had a kamra inlay implanted.The doctor reported the inlay turned greyish, cornea is not clear, inlay is depressed in the stroma, and corneal edema is present.An aggressive steroid regimen of tobrason and hylokomod was initiated on (b)(6) 2015.
|